SCHEMBL7318709

SCHEMBL7318709

CN(C)/C=C1/CCN(C(=O)c2ccc([N+](=O)[O-])cc2Cl)c2ncccc2C1=O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TP53 P04637 1/20 0.39
KMT2A Q03164 5/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
MAPT P10636 5/20 0.37
MEN1 O00255 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CA2 P00918 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231227 1.00 ALDH1A1 (0.39) ALDH1A1TP53KMT2ANPC1RAB9A
SCHEMBL5232572 0.86 MAPT (0.39) ALDH1A1RAB9AMAPTSMN1; SMN2CA2
SCHEMBL5232579 0.86 MAPT (0.39) ALDH1A1RAB9AMAPTSMN1; SMN2CA2
SCHEMBL8689025 0.82 P2RX7 (0.38) ALDH1A1TP53KMT2AMAPTMEN1
SCHEMBL5234088 0.81 ALDH1A1 (0.45) ALDH1A1TP53KMT2ANPC1RAB9A
SCHEMBL8691503 0.78 DRD2 (0.39) ALDH1A1KMT2ARAB9APKMMAPT
SCHEMBL5233477 0.78 KMT2A (0.39) ALDH1A1TP53KMT2ANPC1RAB9A
SCHEMBL5233480 0.78 KMT2A (0.39) ALDH1A1TP53KMT2ANPC1RAB9A
SCHEMBL5238511 0.74 ALDH1A1 (0.39) ALDH1A1KMT2ANPC1MAPTMEN1
SCHEMBL5238517 0.74 ALDH1A1 (0.39) ALDH1A1KMT2ANPC1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022295-A1 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS AMERICAN CYANAMID COMPANY (US) 1996-07-25 WO disclosed
US-5532235-A TO TREAT EXCESS RENAL REABSORPTION AMERICAN CYANAMID COMPANY (US) 1996-07-02 US disclosed